Pfizer

Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have...

Gastric Analysis

Microscopic analysis

CTLA4 Mab rDNA Pfizer

Body composition analysis

SWOT, Strategy and Corporate Finance Report - Marketline

​SWOT, Strategy and Corporate Finance Reports published last year by MarketLineComprehensive source of company data and information. Each report covers the company’s structure, operation, SW...

​SWOT, Strategy and Corporate Finance Report - Marketline

​SWOT, Strategy and Corporate Finance Reports published last year by MarketLineComprehensive source of company data and information. Each report covers the company’s structure, operation, SWOT ana...

Global Heparin Market 2011-2015: MarketResearchReports.Biz

ALBANY, New York, November 21, 2012 /PRNewswire/ -- New Market Research Report Added in MarketResearchReports.Biz Reports Database Global Heparin Market 2011-2015 TechNavio'...

Pfizer: A Long-Term Value Buy

By Stock Gamer:Shares of Pfizer (PFE) have returned 21.8% over the past 12 months. At $26.61 per share, the stock is now trading very close to its 52-week high of $26.88, and offers an attractive expe...

ResearchMoz.us: Global Pneumococcal Vaccine Market 2011 - 2015 - Market Research Report

ALBANY, New York, October 16, 2012 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Global Pneumococcal Vaccine Market 2011-2015 TechNavio's analysts forecast the Global Pneumoc...

Pfizer: Company profile

  Return to top 50 pharma list Summary Website: Pfizer Headquarters: New York, USA Ticker: PFE (NYSE) SEC: Pfizer Recent deal news: Pfizer deal news at Current Partnering Must read report: Partne...

Janssen Pharmaceuticals: Dr Paul Stoffels shares his views in a “SWOT” analysis of the biopharmaceutical industry

In this episode of PharmaTelevision News Review filmed at #BIO 2012 in Boston Fintan Walton talks to Dr Paul Stoffels, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Johnson & Johnson, Pharmaceuticals: Dr Paul Stoffels shares his views in a “SWOT” analysis of the biopharmaceutical industry

In this episode of PharmaTelevision News Review filmed at #BIO 2012 in Boston Fintan Walton talks to Dr Paul Stoffels, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Undergraduate Training in Orthopaedic and Trauma Surgery: Analysis of Contextual and Structural Implementation Models for Undergraduate Training in the Newly Combined Specialty.

AIM: The fusion of orthopaedic and trauma surgery into a combined specialty requires a new evaluation of postgraduate and undergraduate training. This study presents a structured analysis of the imple...

Reply to: Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.

Erratum to: Pharmacokinetic-pharmacodynamic relationship of bosutinib in patients with chronic-phase chronic myeloid leukemia.

Causal reasoning on biological networks: interpreting transcriptional changes.

The interpretation of high-throughput datasets has remained one of the central challenges of computational biology over the past decade. Furthermore, as the amount of biological knowledge increases, i...

Response to the Comment on the Article "Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions"